Literature DB >> 11083069

Emotional disorders in patients with different types of pituitary adenomas and factors affecting the diagnostic process.

J Flitsch1, S Spitzner, D K Lüdecke.   

Abstract

A prospective study of 48 patients with pituitary adenomas, 19 adenomas causing Cushing's disease, 18 adenomas causing acromegaly, and 11 clinically hormone-inactive adenomas (inactive adenomas), was performed to study emotional disorders occurring before and after transsphenoidal microsurgery. Factors which led to an obvious delay in the diagnostic process were identified. - The tools utilised were an interview and repeated personality assessments. The personality assessments were begun preoperatively and continued for about half a year postoperatively. The interview data, including retrospective statements regarding somatic difficulties, was analysed. - The thesis of a uniform psychopathology due to the influence of elevated hormone levels, and a lack in patients' sensitivity towards their changed appearance in acromegaly could not be confirmed. A high variability of reported emotional problems was found. The most common psychopathological signs for Cushing's disease were excitability and depression, for acromegaly fatigue/loss of energy was the most frequent complaint. Six to eight months postoperatively, a majority of patients noticed an increase of physical well-being. In acromegaly, the time span between first consultation and diagnosis averaged 6.2 years, in Cushing's disease it was 4.3 years, and in inactive adenomas it was 3.9 years. Only a small part of the delay in diagnosis, less than two years, could be attributed to the patients' hesitation to consult a physician.

Entities:  

Mesh:

Year:  2000        PMID: 11083069     DOI: 10.1055/s-2000-8144

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  10 in total

1.  Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5.

Authors:  Xiaoju Yang; Erin R Ewald; Yuqing Huo; Kellie L Tamashiro; Roberto Salvatori; Akira Sawa; Gary S Wand; Richard S Lee
Journal:  Biochem Biophys Res Commun       Date:  2012-03-16       Impact factor: 3.575

2.  Alterations in DNA methylation of Fkbp5 as a determinant of blood-brain correlation of glucocorticoid exposure.

Authors:  Erin R Ewald; Gary S Wand; Fayaz Seifuddin; Xiaoju Yang; Kellie L Tamashiro; James B Potash; Peter Zandi; Richard S Lee
Journal:  Psychoneuroendocrinology       Date:  2014-03-20       Impact factor: 4.905

Review 3.  Environmental stressors and epigenetic control of the hypothalamic-pituitary-adrenal axis.

Authors:  Richard S Lee; Akira Sawa
Journal:  Neuroendocrinology       Date:  2014-11-18       Impact factor: 4.914

Review 4.  Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.

Authors:  Lindsey J Anderson; Jamie M Tamayose; Jose M Garcia
Journal:  Mol Cell Endocrinol       Date:  2017-06-09       Impact factor: 4.102

Review 5.  Cushing's disease: a surgical view.

Authors:  D K Lüdecke; J Flitsch; U J Knappe; W Saeger
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Quality of life in female patients with acromegaly.

Authors:  O Celik; P Kadioglu
Journal:  J Endocrinol Invest       Date:  2012-11-26       Impact factor: 4.256

7.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

8.  [Acromegaly-associated lesions of the nasal mucosa. Case report].

Authors:  J Flitsch; D K Lüdecke; W Saeger; J A Veit; F U Metternich
Journal:  HNO       Date:  2009-08       Impact factor: 1.284

9.  Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.

Authors:  Sang Ouk Chin; Choon Hee Chung; Yoon-Sok Chung; Byung-Joon Kim; Hee Young Kim; In-Ju Kim; Jung Guk Kim; Min-Seon Kim; Seong-Yeon Kim; Eun Jig Lee; Ki Young Lee; Sung-Woon Kim
Journal:  BMJ Open       Date:  2015-06-10       Impact factor: 2.692

10.  Acromegaly Quality of Life Questionnaire (AcroQoL).

Authors:  Xavier Badia; Susan M Webb; Luis Prieto; Nuria Lara
Journal:  Health Qual Life Outcomes       Date:  2004-02-27       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.